SOURCE: SkyLynx Communications, Inc.

March 28, 2007 09:30 ET

VETCO Hospitals, Inc. Announces Start of Anesthesia Free Dentals in Vaccine Clinics

SARASOTA, FL -- (MARKET WIRE) -- March 28, 2007 -- SkyLynx Communications (OTCBB: SKYC), a company engaged in the growth pet healthcare industry, and VETCO Hospitals, which operates 155 vaccine clinics and five full service veterinary hospitals inside of PETCO stores in five western states, announces the introduction of non-anesthetic dentals in its expanding network of mobile vaccination clinics.

Bryan Shobe, CEO of VETCO, said, "This ground-breaking procedure expands the offering of our vaccine clinics dramatically. Under the same cost structure we can expand volume and profits with a minimum increase in expense. In addition, we can save our valued customers money over the traditional dental procedure in a full service pet hospital. Most importantly, however, is the fact that now pet owners can provide regular oral care for pets without need of sedation, a serious impediment in the past."

Mr. Shobe went on to explain, "Many pets cannot be anesthetized without serious risk, so adequate dental care is rare. The bacteria that build in the oral cavity can contribute to serious illnesses such as heart disease, kidney and liver infections. Now, with regular dentals (every 6 months vs. every 3 - 5 years), pet owners can lower the overall healthcare costs of their pets, extend their life expectancy, and avoid the dreaded 'dog breath!'"

"This is the next in a series of VETCO's efforts to expand its product offering to its extensive database of pet owners, following on the heels of the successful launch earlier this year of the joint venture with PetCareRx of internet sales from our new USPetHealthRx website (," Mr. Shobe said.

"We are very pleased with our customer interest in this new ground-breaking procedure. Our first weekend test was extremely positive and bodes well for the expansion of this new service."

The American Pet Products Manufacturers estimates that 69.1 million American households, 63% of all American homes, own a pet. Spending on pets in the US is expected to reach $38.4 billon this year, up from $36.3 billion last year. Of that, vet care will account for around $9.4 billion, and supplies and OTC medicines will be $9.3 billion. In 2005, spending in both categories was $8.7 billion. APPMA's 2005-2006 National Pet Owners Survey notes that 52 percent of dogs, 24 percent of cats, 36 percent of saltwater fish, 15 percent of freshwater fish, 5 percent of birds, 11 percent of small animals and 8 percent of reptiles are given medications and/or drugs.

About SkyLynx (

SkyLynx Communications, Inc., based in Sarasota, FL, through its wholly owned subsidiary VETCO Hospitals, is building a nationwide company to create a more efficient system to deliver pet healthcare in the US. VETCO Hospitals operates 155 vaccine clinics and five (5) full service veterinary hospitals inside of PETCO stores in five (5) western states. In addition, it operates an e-service website, ( and a joint venture e-commerce web site USPetHeatlhRX ( with PetcareRX. It intends to develop products and services for Pet Tracking, E-Commerce sales and acquiring additional veterinary hospitals within its database market.

About PetCareRX

PetCareRx is one of the largest online retailers of pet pharmaceuticals and supplies in North America. Founded in 1998 and based in Lynbrook, New York, PetCareRx has always been dedicated to providing pets and their owners with the medications that they need at very favorable pricing and with the highest level of customer service and convenience.

Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Contact Information

  • Contact:
    Bryan Shobe